Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,454,088
+$800,214 QoQ
Shares Held
131,354
+95.3% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 199 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$70,392
PutShares
16,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. REPL ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in REPL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,454,088 | 131,354 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $653,874 | 67,271 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $300,871 | 71,807 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $70,392 | 16,800 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $631,060 | 67,929 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $134,072 | 13,751 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $223,817 | 18,482 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $214,421 | 19,564 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $149,345 | 17,716 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $432,054 | 18,607 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,277,047 | 72,313 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,093,312 | 76,960 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $549,466 | 31,434 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $732,007 | 43,110 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 | $1,476,134 | 38,421 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,081,640 | 35,452 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,690,414 | 70,522 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $712,031 | 30,931 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $580,570 | 23,363 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $549,596 | 55,125 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||